3. Direction and organization

The Institute for Research in Biotherapy (IRB) associates the University Hospital of Montpellier (CHU Montpellier), the INSERM and the University Montpellier I (UM1).

3.1 Direction Comittee

The direction committe is the entity that defines the common rules in terms of organization, operation, hygiene and safety.

The direction Comittee is composed with :
- The Director of the Institute
- The General Secretary
- The managers of

- the INSERM fundamental research laboratories
- the hospital translational research laboratories
- the common technical platforms
- the private companies.
The Steering Comitte is convened monthly by the Director of the Institute.

3.2 Direction of the IRB

IRB director is Prof. Bernard Klein. IRB director is appointed by the Montpellier CHU director after an international call for director, evaluation of the candidates by an international scientific committee, and agreement with the responsibles of the 3 partner institutions.

The missions of IRB director are:
1 - To define the research and medical strategy of IRB in agreement with the medical priorities in Regenerative Medicine defined by the INSERM, the Montpellier CHU, the School of Medicine and the University Montpellier I.
2 - To organize the call for proposals to recruit basic research leaders (including young group leaders, which will be recognized by the university and research agencies).
3 - To supervise the valorization of the research projects and conduct them to the development of cell or biological drugs, in particular through the biotech companies which will be hosted at IRB.
4 - To develop her/his own research on the premises of the center.
5 - To develop the legal and biomedical support staff for the IRB activities as well as its internal and external communication, in particular with the help of the Center for Clinical Investigation in Biotherapy.
6 - To manage human, technical and financial resources of the center.

3-3. Organisation

The organization and management of the IRB are specified within written regulations proposed by the IRB director and approved by :

- The Director General of the University Hospital of Montpellier (CHRU Montpellier),
- The President Director General of INSERM
- The President of University Montpellier I (UM1).